Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study.
Article in Multiple Sclerosis Journal (August 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Multiple Sclerosis Journal (August 2024)
Article in Cureus (January 2024)
Article in Therapeutic Advances in Neurological Disorders (January 2024)